BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2272 related articles for article (PubMed ID: 33138045)

  • 1. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
    Stroppa EM; Toscani I; Citterio C; Anselmi E; Zaffignani E; Codeluppi M; Cavanna L
    Future Oncol; 2020 Jul; 16(20):1425-1432. PubMed ID: 32403946
    [No Abstract]   [Full Text] [Related]  

  • 3. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A
    Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
    Tadolini M; Codecasa LR; García-García JM; Blanc FX; Borisov S; Alffenaar JW; Andréjak C; Bachez P; Bart PA; Belilovski E; Cardoso-Landivar J; Centis R; D'Ambrosio L; Luiza De Souza-Galvão M; Dominguez-Castellano A; Dourmane S; Fréchet Jachym M; Froissart A; Giacomet V; Goletti D; Grard S; Gualano G; Izadifar A; Le Du D; Marín Royo M; Mazza-Stalder J; Motta I; Ong CWM; Palmieri F; Rivière F; Rodrigo T; Silva DR; Sánchez-Montalvá A; Saporiti M; Scarpellini P; Schlemmer F; Spanevello A; Sumarokova E; Tabernero E; Tambyah PA; Tiberi S; Torre A; Visca D; Zabaleta Murguiondo M; Sotgiu G; Migliori GB
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32457198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
    Scarsi M; Piantoni S; Colombo E; Airó P; Richini D; Miclini M; Bertasi V; Bianchi M; Bottone D; Civelli P; Cotelli MS; Damiolini E; Galbassini G; Gatta D; Ghirardelli ML; Magri R; Malamani P; Mendeni M; Molinari S; Morotti A; Salada L; Turla M; Vender A; Tincani A; Brucato A; Franceschini F; Furloni R; Andreoli L
    Ann Rheum Dis; 2020 Oct; 79(10):1286-1289. PubMed ID: 32732245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
    Della-Torre E; Campochiaro C; Cavalli G; De Luca G; Napolitano A; La Marca S; Boffini N; Da Prat V; Di Terlizzi G; Lanzillotta M; Rovere Querini P; Ruggeri A; Landoni G; Tresoldi M; Ciceri F; Zangrillo A; De Cobelli F; Dagna L; ;
    Ann Rheum Dis; 2020 Oct; 79(10):1277-1285. PubMed ID: 32620597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
    [No Abstract]   [Full Text] [Related]  

  • 11. Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
    Bartiromo M; Borchi B; Botta A; Bagalà A; Lugli G; Tilli M; Cavallo A; Xhaferi B; Cutruzzulà R; Vaglio A; Bresci S; Larti A; Bartoloni A; Cirami C
    Transpl Infect Dis; 2020 Aug; 22(4):e13286. PubMed ID: 32279418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
    Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection.
    Di Perri G
    Infez Med; 2020 Jun; 28(suppl 1):52-56. PubMed ID: 32532939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
    Sekhavati E; Jafari F; SeyedAlinaghi S; Jamalimoghadamsiahkali S; Sadr S; Tabarestani M; Pirhayati M; Zendehdel A; Manafi N; Hajiabdolbaghi M; Ahmadinejad Z; Kouchak HE; Jafari S; Khalili H; Salehi M; Seifi A; Golestan FS; Ghiasvand F
    Int J Antimicrob Agents; 2020 Oct; 56(4):106143. PubMed ID: 32853672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal Visceral Infarction in 3 Patients with COVID-19.
    Besutti G; Bonacini R; Iotti V; Marini G; Riva N; Dolci G; Maiorana M; Spaggiari L; Monelli F; Ligabue G; Guaraldi G; Rossi PG; Pattacini P; Massari M
    Emerg Infect Dis; 2020 Aug; 26(8):1926-1928. PubMed ID: 32396504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
    Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
    Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.
    Goicoechea M; Sánchez Cámara LA; Macías N; Muñoz de Morales A; Rojas ÁG; Bascuñana A; Arroyo D; Vega A; Abad S; Verde E; García Prieto AM; Verdalles Ú; Barbieri D; Delgado AF; Carbayo J; Mijaylova A; Acosta A; Melero R; Tejedor A; Benitez PR; Pérez de José A; Rodriguez Ferrero ML; Anaya F; Rengel M; Barraca D; Luño J; Aragoncillo I
    Kidney Int; 2020 Jul; 98(1):27-34. PubMed ID: 32437770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 114.